Head-to-head · WeighScore
LunaRx vs Sumbare Wellness
The verdict
Sumbare Wellness takes it — 61.9/100 to 61.2/100, but only just.
Sumbare Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Langhorne, Pennsylvania telehealth platform selling compounded semaglutide, tirzepatide and a low-dose GLP-1 protocol on one flat $199/month plan, with the price confirmed only after a provider reviews you. LunaRx is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | LunaRx | Sumbare Wellness |
|---|---|---|
| WeighScore | 61.2/100 | 61.9/100 |
| Grade | C | C |
| Scorecard rank | #299 | #281 |
| Semaglutide | $199/mo (starting dose, compounded) | $199/mo (all doses, compounded) |
| Tirzepatide | Not disclosed | $199/mo (all doses, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #299 · C
Strengths
- Pairs GLP-1 with muscle-protective peptides (e.g., CJC-1295/Ipamorelin, NAD+) to defend lean mass during fat loss
- Structured, physician-directed off-ramp taper with GI-reset support instead of an indefinite prescription
- Bilingual care in English and Spanish across intake, messaging, and consults
- Care directed through a named independent medical group (CareNexus Clinic PC); $0 charged if you are not approved
- Published clinical support hours (Mon–Fri, CT) with phone, email, and secure messaging; cancel anytime
Where it loses points
- Only a "from $199/mo" starting price is published; tirzepatide and per-tier pricing are confirmed only after a provider review
- Compounding pharmacy partners are not named on the site — a transparency gap
- No LegitScript or PCAB verification is displayed
- States served are not published; the site claims "telehealth nationwide" but the Terms limit service to states where LunaRx is licensed
- Compounded medications are not FDA-approved (the site discloses this)
Graded #281 · C
Strengths
- One flat $199/month price covering medication, provider review and shipping, with no consultation fee and no dose-change surcharge
- Charges nothing if a provider does not approve you
- Offers a deliberate low-dose microdosing protocol aimed at body composition, which most competitors do not break out
- Publishes a named legal entity, a US mailing address and a working phone number
- Pre-screening quiz is short and asks your goal before any medical question
Where it loses points
- Cancellation terms contradict three ways: the homepage says cancel anytime, the Terms say 48 hours notice, the FAQ says 30 days
- Availability is unclear: the homepage counter reads 3 states while the treatment pages say telehealth nationwide, and no state list is published
- Its chart cites placebo-controlled trials of compounded semaglutide and tirzepatide, which do not exist; those trials studied the branded drugs
- No compounding pharmacy is named, and neither 503A nor 503B appears anywhere on the site
- Any returned prescription is charged a $35 disposal fee, and prescription orders cannot be cancelled at all after 24 hours
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.